The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Exelixis Inc

Nasdaq: EXEL
Last

(U.S.) $1.36

Today's change0.00 0.00%
Updated December 17 4:00 PM EST. Delayed by at least 15 minutes.
 

Exelixis Inc

Nasdaq: EXEL
Last

(U.S.) $1.36

Today's change0.00 0.00%
Updated December 17 4:00 PM EST. Delayed by at least 15 minutes.

Exelixis Inc closed at (U.S.)$1.36.

Over the last five days, shares have gained 0.74%, but are down 77.81% for the last year to date. Shares have underperformed the S&P 500 by 88.99% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $1.36
  • High--
  • Low--
  • Bid / Ask(U.S.) $1.15 / (U.S.) $1.60
  • YTD % change-77.81%
  • Volume0
  • Average volume (10-day)1,890,289
  • Average volume (1-month)2,053,589
  • Average volume (3-month)2,719,147
  • 52-week range(U.S.) $1.28 to (U.S.) $8.41
  • Beta2.51
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.47
Updated December 17 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1,272.72%

Exelixis Inc has a net profit margin of -1,272.72%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue6754
Total other revenue--------
Total revenue6754
Gross profit6654
Total cost of revenue1000
Total operating expense58687064
Selling / general / administrative10161514
Research & development44515550
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)4000
Other operating expenses, total--------
Operating income-52-62-65-60
Interest income (expense), net non-operating-12-12-12-12
Gain (loss) on sale of assets------0
Other--------
Income before tax-63-73-75-71
Income after tax-63-73-75-71
Income tax, total--000
Net income-63-73-75-71
Total adjustments to net income--------
Net income before extra. items-63-73-75-71
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-63-73-75-71
Inc. avail. to common incl. extra. items-63-73-75-71
Diluted net income-63-73-75-71
Dilution adjustment0--0--
Diluted weighted average shares195195192184
Diluted EPS excluding extraordinary itemsvalue per share-0.32-0.38-0.39-0.38
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.30-0.37-0.39-0.38